U.S. flag

An official website of the United States government

NM_005861.4(STUB1):c.829C>T (p.Gln277Ter) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jul 23, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002244433.6

Allele description [Variation Report for NM_005861.4(STUB1):c.829C>T (p.Gln277Ter)]

NM_005861.4(STUB1):c.829C>T (p.Gln277Ter)

Genes:
STUB1:STIP1 homology and U-box containing protein 1 [Gene - OMIM - HGNC]
JMJD8:jumonji domain containing 8 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_005861.4(STUB1):c.829C>T (p.Gln277Ter)
HGVS:
  • NC_000016.10:g.682406C>T
  • NG_034141.1:g.7296C>T
  • NG_132623.1:g.730C>T
  • NM_001005920.4:c.*388G>AMANE SELECT
  • NM_001293197.2:c.613C>T
  • NM_001323918.3:c.*422G>A
  • NM_001323919.3:c.*388G>A
  • NM_001323920.3:c.*388G>A
  • NM_001323922.3:c.*422G>A
  • NM_005861.4:c.829C>TMANE SELECT
  • NP_001280126.1:p.Gln205Ter
  • NP_005852.2:p.Gln277Ter
  • NC_000016.9:g.732406C>T
  • NM_005861.2:c.829C>T
  • NR_136650.3:n.1281G>A
  • NR_136651.3:n.1286G>A
  • NR_136652.3:n.1196G>A
Protein change:
Q205*
Links:
dbSNP: rs2151507113
NCBI 1000 Genomes Browser:
rs2151507113
Molecular consequence:
  • NM_001005920.4:c.*388G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001323918.3:c.*422G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001323919.3:c.*388G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001323920.3:c.*388G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001323922.3:c.*422G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NR_136650.3:n.1281G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_136651.3:n.1286G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_136652.3:n.1196G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001293197.2:c.613C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_005861.4:c.829C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002513073GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(Jul 23, 2024)
germlineclinical testing

Citation Link,

SCV003219933Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 12, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV002513073.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation, as the last 27 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Has not been previously published as pathogenic or benign to our knowledge

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003219933.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1683911). This variant has not been reported in the literature in individuals affected with STUB1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln277*) in the STUB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 27 amino acid(s) of the STUB1 protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024